These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2870837)

  • 21. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
    Am J Cardiol; 1983 Dec; 52(10):1230-7. PubMed ID: 6359851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timolol and bendroflumethiazide in the treatment of hypertension.
    Karatzas NB; Papazachos G; Clouva P; Tsaknakis T
    J Int Med Res; 1979; 7(3):215-20. PubMed ID: 378730
    [No Abstract]   [Full Text] [Related]  

  • 24. [Field trial with a new betablocker (Solgol)].
    Piergies A; Schimert G
    MMW Munch Med Wochenschr; 1980 Oct; 122(42):1473-6. PubMed ID: 6110182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new drug combination: metipranolol with butizide in the treatment of arterial hypertension].
    De Cesaris R; Balestrazzi M; Procaccio P; Dell'Orco M
    Clin Ter; 1981 Oct; 99(1):43-7. PubMed ID: 6118217
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta-blockers and arterial hypertension: comparison between nadolol and propranolol].
    Abate G; Polimeni RM; Di Peppe MC; Guarino F; Troja C; Marisi F; Cerritelli E; Brillante C; De Angelis M
    Clin Ter; 1982 Aug; 102(3):283-291. PubMed ID: 7140182
    [No Abstract]   [Full Text] [Related]  

  • 28. Nadolol and placebo comparison study in the prophylactic treatment of migraine.
    Freitag FG; Diamond S
    J Am Osteopath Assoc; 1984 Dec; 84(4):343-7. PubMed ID: 6150909
    [No Abstract]   [Full Text] [Related]  

  • 29. [The treatment of ambulant hypertensive patients with a combination of a saluretic and a beta-receptor blocker (author's transl)].
    Schlesinger P; Fadel Tabet F
    MMW Munch Med Wochenschr; 1981 Oct; 123(42):1589-92. PubMed ID: 6118831
    [No Abstract]   [Full Text] [Related]  

  • 30. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
    Zonis BIa; Brin VB
    Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
    [No Abstract]   [Full Text] [Related]  

  • 31. Nadolol and placebo comparison study in the prophylactic treatment of migraine.
    Ryan RE; Ryan RE; Sudilovsky A
    Panminerva Med; 1982; 24(2):89-94. PubMed ID: 6128710
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nadolol, a long-term acting beta blocking agent, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765278
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
    Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of nadolol in coronary disease].
    Tkaczewski W; Goch JH; Dziekański S
    Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
    Tirlapur VG; Mir MA
    Postgrad Med J; 1983; 59 Suppl 2():30-4. PubMed ID: 6136959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mitral valve prolapse. Evaluation of the efficacy of nadolol on the control of clinical symptoms and on the normalization of electrocardiographic tracings].
    Bichuette HS
    Arq Bras Cardiol; 1984 Dec; 43(6):449-56. PubMed ID: 6152676
    [No Abstract]   [Full Text] [Related]  

  • 38. Nadolol and antidepressant response.
    Faber R
    Biol Psychiatry; 1983 Nov; 18(11):1338-9. PubMed ID: 6140034
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765448
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of hypotensive effect of nadolol].
    Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
    Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.